Over-the-counter supplements called nootropics — sometimes called “Nature’s Adderall” — promise to boost cognition and focus.

The supplements space is ripe for innovation, and Riize Up’s approach is catching the attention of influencers and industry ...

Apple's iPhone 18 Pro series may feature under-display Face ID and a new punch-hole camera design, moving away from the ...

The face of depression isn't always tear-streaked cheeks; sometimes, it smiles back at you from across the dinner table or on ...

The War on Drugs are unfortunately unable to perform with Sam Fender in London and Newcastle this June.” No further information has currently been shared, but CMAT will still be supporting at ...

Dr Amit Bansal was booked by Patiala police on April 16 under multiple sections of the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985 — including Sections 22, 25, 26, 29 ...

With this figure in mind, it's no wonder Wall Street investment banks are telling anyone who will listen that sales of anti-obesity drugs could soar. The needles used to inject Novo Nordisk's and ...

Orforglipron, a new nonpeptide GLP-1 drug, may provide easier access for the treatment of Type 2 diabetes and obesity without injections. According to early clinical trial results shared on ...

Eli Lilly's oral GLP-1 pill helped patients regulate blood sugar and lose weight The drug reduced weight by 16 pounds, on average, at the highest dose The pill could make treatment easier for ...

India's drug regulatory body, CDSCO, has banned 35 fixed-dose combination drugs, including painkillers and anti-diabetics, due to safety concerns. These combinations were manufactured and sold ...

Eli Lilly’s new obesity and diabetes pill has shown it can lower blood sugar and aid weight loss in a late-stage trial, sending shares in the US drugmaker up nearly 15 per cent in Wall Street ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity ...